0001760174-18-000001.txt : 20181128 0001760174-18-000001.hdr.sgml : 20181128 20181127191934 ACCESSION NUMBER: 0001760174-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: 4a5 FILED AS OF DATE: 20181128 DATE AS OF CHANGE: 20181127 EFFECTIVENESS DATE: 20181128 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Coeptis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001760174 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326656 FILM NUMBER: 181203949 BUSINESS ADDRESS: STREET 1: 105 BRADFORD ROAD STREET 2: SUITE 420 CITY: WEXFORD STATE: PA ZIP: 15090 BUSINESS PHONE: (724) 934-6467 MAIL ADDRESS: STREET 1: 105 BRADFORD ROAD STREET 2: SUITE 420 CITY: WEXFORD STATE: PA ZIP: 15090 D 1 primary_doc.xml X0708 D LIVE 0001760174 Coeptis Pharmaceuticals, Inc. 105 BRADFORD ROAD SUITE 420 WEXFORD PA PENNSYLVANIA 15090 (724) 934-6467 DELAWARE None None Corporation true 2018 David Mehalick 105 Bradford Road Suite 420 Wexford PA PENNSYLVANIA 15090 Executive Officer Director Promoter CEO Dan Yerace 105 Bradford Road Suite 420 Wexford PA PENNSYLVANIA 15090 Executive Officer Director Vice-President Pharmaceuticals Decline to Disclose 06b 4a5 false true false true true false 60000 18000000 0 18000000 true 0 0 1800000 true 0 true See the Issuer's Confidential Private Placement Memorandum. 0 true See the Issuer's Confidential Private Placement Memorandum false Coeptis Pharmaceuticals, Inc. David Mehalick David Mehalick CEO 2018-11-27